Interleukin-2 receptor antibody vs ATG for induction immunosuppression after liver transplantation: initial results of a prospective randomized trial.
Lemmens
H P
HP
Department of Surgery, Virchow Clinic, Free University, Berlin, Germany.
Langrehr
J M
JM
Bechstein
W O
WO
Blumhardt
G
G
Keck
H
H
Lüsebrink
R
R
Knoop
M
M
Lohmann
R
R
Tullius
S
S
Lobeck
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications / Q000453:epidemiology; D011446:Prospective Studies; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D015996:Survival Rate
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015375:Receptors, Interleukin-2; C079843:inolimomab